Topic: Structural Heart

Abbott Laboratories has won a nod from FDA for a new alternative surgical technique for […]

Dive Brief: Abbott is warning doctors of the potential for harm to patients from two […]

Edwards Lifesciences changed the way heart valve disease is treated in 2019. It was not […]

MILAN, Dec. 5, 2019 /PRNewswire/ — InnovHeart s.r.l., a developer of novel transcatheter mitral valve replacement (TMVR) systems […]

Dive Brief: Edwards Lifesciences intends to match the high it set this year for R&D spending […]

Dive Brief: Edwards Lifesciences issued fiscal guidance for 2020 Thursday morning, targeting sales in the […]

A long-term followup study on Boston Scientific’s (NYSE:BSX) Watchman heart implant shows low risk of hemorrhagic stroke […]

Dive Brief: A retrospective cohort study has linked pulmonary hypertension to increased mortality and readmission […]

Dive Brief: LivaNova will end its transcatheter mitral valve replacement program as part of a […]

BioVentrix is getting closer to bringing its transcatheter-based structural cardiovascular device to treat heart failure […]

Dive Brief: Two registry studies have linked Edwards Lifesciences’ transcatheter aortic valve replacement (TAVR) system […]

Dive Brief: Edwards Lifesciences is recalling a guide sheath used with its Pascal transcatheter mitral […]

Dive Brief: Edwards Lifesciences’ Sapien 3 transcatheter heart valve is now allowed for use in […]

Boston Scientific’s Lotus Edge might be one of the biggest and most significant FDA approvals […]

Dive Brief: Edwards Lifesciences credited strong clinical trial results from its Partner 3 study, which […]

Dive Brief: Edwards Lifesciences credited strong clinical trial results from its Partner 3 study, which […]

For the past 17 years, the Cleveland Clinic has predicted what the top 10 medical […]

Edwards Lifesciences (NYSE:EW) shares jumped after hours today on third-quarter results that topped the consensus forecast. […]

Clinical data presented at the 2019 European Cardio-Thoracic Surgery (EACTS) annual meeting (3-5 October, Lisbon, […]

Last month, Medtronic announced receipt of U.S. Food and Drug Administration (FDA) approval for and […]

Edwards Lifesciences (NYSE:EW) is slated to add a $100 million expansion and 500 new jobs by […]

Valfix Medical this week filed an SEC Form D reporting that it sold more than $1 […]

4C Medical Technologies secured more than $8 million in an equity offering it hopes will reach […]

SAN FRANCISCO, Sept. 29, 2019 /PRNewswire/ — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for […]

Medtronic has won a nod from FDA for the Evolut PRO+ TAVR System – a […]

TORONTO, Sept. 23, 2019 /PRNewswire/ – Baylis Medical announced today the successful first MitraClip™ procedure performed using […]

According to a new study, a new approach to self-expanding transcatheter aortic valve replacement could […]

Dive Brief: Physicians were unable to complete 1% of transcatheter aortic valve replacements from 2011 […]

Boston Scientific has announced the key data that will be presented at the Transcatheter Cardiovascular Therapeutics […]

Transcatheter aortic valve replacement (TAVR) procedures have become a popular way of treating aortic valve […]

AtriCure has entered into a definitive agreement to acquire SentreHEART, which developed the LARIAT device […]

Foldax today announced first-in-human use of its Tria heart valve in an FDA early feasibility study […]

On 16 August, the US Food and Drug Administration (FDA) approved Edwards Lifesciences’ Sapien 3 […]

Cardiac Dimensions today touted a clinical study of its Carillon mitral contour system in treating the […]

CroíValve said today that it secured more than $4 million in additional financing as it develops […]